| 中药治疗肝纤维化作用机理实验研究进展 |
| |
| 引用本文： | 王颖芳,王宇亮.中药治疗肝纤维化作用机理实验研究进展[J].河南中医学院学报,2003,18(2):83-85. |
| |
| 作者姓名： | 王颖芳 王宇亮 |
| |
| 作者单位： | 河南中医学院 2000级研究生
(王颖芳)，河南中医学院 2000级研究生(王宇亮) |
| |
| 摘 要： | 中药治疗肝纤维化作用机理实验研究可综述如下几个方面：①保肝，抗脂质过氧化；②抑制HSC的激活；③促进ECM降解，减少ECM沉积；④改善肝脏微循环，抑制肝窦毛细血管化；⑤综合作用。但是，值得注意的问题是：①要建造有价值的动物模型；②要制订客观统一的疗效标准。
|
| 关 键 词： | 肝纤维化 作用机理 实验研究 中药 |
| 文章编号： | 1006-3234(2003)02-0083-03 |
| 修稿时间： | 2002年12月5日 |
Recent Development in the Experimental Study of Chinese Medication for Fibrosis of Liver |
| |
| Wang Yingfang,Wang Yuliang.Recent Development in the Experimental Study of Chinese Medication for Fibrosis of Liver[J].Journal of Henan University of Chinese Medicine,2003,18(2):83-85. |
| |
| Authors: | Wang Yingfang Wang Yuliang |
| |
| Abstract: | The experimental study of the mechanism includes the following aspects. Chinese medication can protect liver and prevent lipid peroxidation, and inhibit HSC activation. It can also promote degradation and reduce sedimentation of ECM. It also improves microcirculation of liver and prevent capillarity of hepatic sinusoid. In addition it has comprehensive function. Yet it is noteworthy to establish worthwhile animal modles as well as to set up a unified objective standard for therapeutic effect. |
| |
| Keywords: | fibrosis of liver Chinese medication mechanism experimental study summary |
| 本文献已被 CNKI 维普 等数据库收录！ |
